Join our series of webinars for free - sign up today to reserve your spot
There is rising pressure to move from reactive to proactive and predictive pharmacovigilance. With a comprehensive view into relevant information from intake to post-market surveillance, companies can better mitigate risks and make benefit-risk safety decisions.
The world has been dreaming of self-driving cars for over a century. Unimaginable to the average person even 10 years ago, today most developed countries are working on laws to regulate them. Though we might still be a few years away, safety case processing and signal management are also on their way to running in auto-pilot mode and this is good news for your safety teams.
Decreasing budgets and increasing case volumes require a more efficient model in drug safety. Is automation part of that model? A recent survey conducted by a global consultancy found that workflow automation is rated as the most critical buying factor when large biopharmas are choosing safety software. Despite the many bold claims around automation in the industry, few have any real-world proof points to support them.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started.”
Please join us for a one-hour webinar, in which you will learn how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
For safety organizations to be strategic, companies need to invest in safety science and increase its cross-functional role. Leveraging modern technologies and redefining processes to enable seamless collaboration between departments from preclinical to commercial, can drive greater impact from safety science.
Join us as we discuss how the role of safety science evolves as companies grow, different PV organizational models, how technology can improve, and measuring the value of safety science.
Managing safety cases is becoming more complex due to ever-increasing volume and variety of data. These common but evolving challenges point to the development of common frameworks leading to industry-wide solutions that can be adapted or tailored to specific needs.
This webcast, co-hosted by Oracle and ICON, will discuss why, from a CRO perspective, the cloud and AI are important milestones on the journey to the new world of safety.
Inspections are a crucial part of any pharmacovigilance program. Now more than ever it's important to have an efficient and harmonized system of inspections. This webinar will dive into discussions on: What to expect from GPvP inspections, how to handle remote inspections in the era of covid19, and using the proper methods and metrics to ensure your inspection was a success. Join Takeda's head of inspections Raj Bhogal and our fantastic panel as they share their perspective on these topics.
During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID-19. Regardless of the great recent advancements in genomic and molecular biology, a viable vaccine approval is still likely to be over a year away.
This webinar will discuss the challenges and safety issues surrounding a vaccine approval at “pandemic speed”.